Yutiq Alternatives Compared
Yutiq | Eylea | Lucentis |
|
---|
Yutiq (fluocinolone) | Eylea (aflibercept) | Lucentis (ranibizumab) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Uveitis, Diabetic Macular Edema. Yutiq may also be used for purposes not listed in this medication guide. |
Prescription only
Eylea / Eylea HD are VEGF (vascular endothelial growth factor) inhibitors that used to treat a variety of eye conditions that may affect your vision, including neovascular (wet) age-related macular... View more |
Prescription only
Prescribed for Macular Degeneration, Macular Edema Following Retinal Vein Occlusion , Diabetic Macular Edema, Macular Edema, Myopic Choroidal Neovascularization, Diabetic Retinopathy. Lucentis may... View more |
Related suggestions Diabetic Macular Edema
|
|||||||||||||||||||||||
More about Yutiq (fluocinolone) | More about Eylea (aflibercept) | More about Lucentis (ranibizumab) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Yutiq has an average rating of 0.0 out of 10 from a total of 2 ratings on Drugs.com. |
Eylea has an average rating of 7.1 out of 10 from a total of 63 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 21% reported a negative effect. |
Lucentis has an average rating of 6.5 out of 10 from a total of 15 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Yutiq side effects in more detail. |
See also: Eylea side effects in more detail. |
See also: Lucentis side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Yutiq prices |
View all Eylea prices |
View all Lucentis prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other fluocinolone brands include: Iluvien, Retisert | Other aflibercept brands include: Eylea HD | Other ranibizumab brands include: Byooviz, Cimerli, Susvimo | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
144 hours |
216 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 8 drugs are known to interact with Yutiq:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 1 drugs are known to interact with Lucentis:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
October 12, 2018 |
N/A |
N/A |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.